Nakao M, Takeuchi T, Yano E
Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.
Int J Clin Pharmacol Ther. 2007 Jan;45(1):30-5. doi: 10.5414/cpp45030.
Excessive benzodiazepine use is a public health concern from clinical and economical perspectives. Although more benzodiazepines are prescribed in Japan than in any other country, no hospital-based report has documented this phenomenon. Therefore, this study compared the prescription frequency of benzodiazepines with that of selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and other antidepressants in a single Japanese hospital over 1 year.
The annual prescription of benzodiazepines was assessed with that of antidepressants using an electronic database of medical records for outpatients at a Japanese tertiary care hospital affiliated with a private university with approximately 600,000 outpatient visits annually.
Groups of departments were analyzed separately (i.e. internal medicine, surgery, neurology, psychiatry, and others). The ratio of the number of prescriptions of anxiolytic benzodiazepines to that of SSRI and SNRI was calculated among the department groups and used as one of indicators comparing the prescriptions of benzodiazepines with those of antidepressants.
Of 644,444 hospital prescriptions, 6.1% were for anxiolytic benzodiazepines, and 5.8% were for hypnotic benzodiazepines. Regarding antidepressants, 1.6% of prescriptions were for SSRIs/SNRIs, 0.8% were for tricyclic antidepressants, and 1.5% were for other antidepressants. Of the benzodiazepine prescriptions, 26.8% were written by the internal medicine group. The ratio of the number of prescriptions for anxiolytic benzodiazepines to that for SSRI and SNRI was highest in the department of internal medicine (ratio = 13.0), followed by surgery (7.6), neurology (4.8), and psychiatry (2.5). With the department of psychiatry as the reference, the tendency to prescribe an anxiolytic benzodiazepine rather than an SSRI or SNRI was statistically significant in the remaining four department groups, after controlling for the effects of patient age and sex in a multiple logistic regression analysis.
Benzodiazepine prescriptions in the Japanese hospital were far more common than prescriptions for antidepressants such as SSRIs and SNRIs, especially in internal medicine. Multi-institutional studies are needed to address this issue in Japanese hospitals, as well as in hospitals in other countries.
从临床和经济角度来看,苯二氮䓬类药物的过度使用是一个公共卫生问题。尽管日本开具的苯二氮䓬类药物处方比其他任何国家都多,但尚无基于医院的报告记录这一现象。因此,本研究比较了一家日本医院在1年时间里苯二氮䓬类药物与选择性5-羟色胺再摄取抑制剂(SSRI)、5-羟色胺和去甲肾上腺素再摄取抑制剂(SNRI)以及其他抗抑郁药的处方频率。
利用一所私立大学附属的日本三级护理医院的门诊电子病历数据库,评估苯二氮䓬类药物的年度处方量与抗抑郁药的年度处方量,该医院每年约有60万门诊人次。
对各科室组分别进行分析(即内科、外科、神经科、精神科和其他科室)。计算各科室组中抗焦虑苯二氮䓬类药物处方数与SSRI和SNRI处方数的比值,并将其作为比较苯二氮䓬类药物与抗抑郁药处方的指标之一。
在644444份医院处方中,6.1%为抗焦虑苯二氮䓬类药物处方,5.8%为催眠苯二氮䓬类药物处方。关于抗抑郁药,1.6%的处方为SSRI/SNRI,0.8%为三环类抗抑郁药,1.5%为其他抗抑郁药。在内科组开具的苯二氮䓬类药物处方中,26.8%是由内科组开具的。抗焦虑苯二氮䓬类药物处方数与SSRI和SNRI处方数的比值在内科最高(比值 = 13.0),其次是外科(7.6)、神经科(4.8)和精神科(2.5)。以精神科为参照,在多因素逻辑回归分析中控制患者年龄和性别影响后,其余四个科室组开具抗焦虑苯二氮䓬类药物而非SSRI或SNRI的倾向具有统计学意义。
在这家日本医院,苯二氮䓬类药物的处方远比SSRI和SNRI等抗抑郁药的处方常见,尤其是在内科。需要开展多机构研究,以解决日本医院以及其他国家医院的这一问题。